department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Suven Life Sciences Ltd · pharmadog

PUBLIC COMPANY

Suven Life Sciences Ltd

updated 1mo ago

community read0 votes

pipeline

6

marketed

1

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(6)

pipeline depth6 products

2Phase 12Phase 21Phase 31Marketed

Pediculosis capitis (Head Lice Infestation)

Dementia Associated With Alzheimer's Disease

Major Depressive Disorder

Cognitive Disorders

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Suven Life Sciences Ltd jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

Alzheimer's Disease1 Infectious Disease1 Major Depression1

mentioned in

0news items

entity-linker matched

usmarapride

Alzheimer's Disease

Active trials

phase3A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsynot yet recruitingn=240
phase2Study Evaluating Safety and Efficacy of Ropanicant in MDD Patientscompletedn=41
phase2Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patientscompletedn=214
phase1Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participantscompletedn=64
phase3Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Typerecruitingn=375
phase2A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexycompletedn=190
phase2SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Studycompletedn=564

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?